Regeneron Pharmaceuticals, Inc.
REGN · NASDAQ
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q2 | July 30, 2026 | — | 3.81B | — | 10.00 | — |
| 2026 Q1 | April 29, 2026 | 3.61B | 3.48B | 6.75 | 8.52 | -6.21% |
| 2025 Q4 | January 30, 2026 | 3.88B | 3.81B | 9.30 | 10.56 | -1.07% |
| 2025 Q3 | October 28, 2025 | 3.75B | 3.59B | 9.63 | 9.44 | +11.82% |
| 2025 Q2 | August 1, 2025 | 3.68B | 3.29B | 10.72 | 8.03 | +2.46% |
| 2025 Q1 | April 29, 2025 | 3.03B | 3.25B | 6.43 | 8.43 | -6.87% |
| 2024 Q4 | February 4, 2025 | 3.79B | 3.74B | 9.90 | 11.62 | +4.53% |
| 2024 Q3 | October 31, 2024 | 3.72B | 3.67B | 11.73 | 11.75 | -9.17% |
| 2024 Q2 | August 1, 2024 | 3.55B | 3.38B | 10.10 | 10.57 | +1.29% |
| 2024 Q1 | May 2, 2024 | 3.15B | 3.23B | 7.97 | 10.20 | +3.78% |
| 2023 Q4 | February 2, 2024 | 3.43B | 3.29B | 10.18 | 10.43 | -1.32% |
| 2023 Q3 | November 2, 2023 | 3.36B | 3.22B | 10.17 | 10.80 | +3.48% |
| 2023 Q2 | August 3, 2023 | 3.16B | 3.02B | 8.79 | 9.92 | +5.37% |
| 2023 Q1 | May 4, 2023 | 3.16B | 3.00B | 8.44 | 9.25 | -6.14% |
| 2022 Q4 | February 3, 2023 | 3.41B | 3.12B | 10.96 | 9.68 | +4.25% |
| 2022 Q3 | November 3, 2022 | 2.94B | 2.92B | 9.98 | 9.65 | -0.24% |